Unfortunately, an evaluation of the IDH2 gene mutation status of the entire MPN-lymphoma cohort was not possible because of unavailability (or poor quality) of the tissue specimens that were acquired for sequencing. The gene discussed is IDH2; the disease is lymphoma.